Z-1855-2012 Class II Terminated
FDA device recall Z-1855-2012 was initiated by Genzyme Corporation on Jun 13, 2012 and is designated Class II. Reason for recall: Sterility of product may be compromised due to packaging defect The recall status is terminated (terminated Jul 24, 2013). Affected quantity: 3880units.
Recall details
- Product Type
- Devices
- Report Date
- Jun 27, 2012
- Initiation Date
- Jun 13, 2012
- Termination Date
- Jul 24, 2013
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 3880units
Product description
seprafilm¿ Procedure Pack ADHESION BARRIER Re-order Number: 5086-02 Product Usage: Seprafilm Adhesion Barrier is indicated for use in patients undergoing abdominal or pelvic laparotomy as an adjunct intended to reduce the incidence, extent and severity of postoperative adhesions between the abdominal wall and the underlying viscera such as omentum, small bowel, bladder, and stomach, and between the uterus and surrounding structures such as tubes and ovaries, large bowel, and bladder.
Reason for recall
Sterility of product may be compromised due to packaging defect
Distribution pattern
Worldwide Distribution - US (nationwide) and the country of S. Korea
Code information
Lot numbers: 11NP620 Exp. 2014 - 09; 11NP630 Exp 2014 - 10; and 11NP649 Exp 2014- 11; 11NP704 Exp 2014 - 11
Source
- Dataset
- openFDA device recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for Z-1855-2012
- openFDA file date
- Nov 19, 2026
- Loaded by RegDataLab
- Nov 20, 2026
Need the full FDA record for Genzyme Corporation? Ask Claude or ChatGPT with the RegDataLab connector and get every site's inspections, Form 483s, warning letters, recalls and import alerts, each with a link to the FDA source. The API key is free: no card.